Asuragen is a molecular diagnostic product company that provides oncology, and clinical testing services for cancer diagnosis.
Business Model:
Revenue: $30M
Employees: 51-200
Asuragen was acquired by
Bio-Techne.
The acquisition happend on 2021-03-03.
Details of the transaction were not public
Address: 2150 Woodward Street
City: Austin
State: TX
Zip: 78744
Country: US
Asuragen is a molecular diagnostic product company that provides oncology, and clinical testing services for cancer diagnosis.
Contact Phone:
+18777771874
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2020 | Debt | $2M |
U.S. Small Business Administration. |
5/2006 | Series A | $49M |
Telegraph Hill Partners |
8/2011 | Venture Round | $5M | 10/2007 | Funding Round | 1 | - |
Merck Global Health Innovation Fund Merck Global Health Innovation Fund |
12/2007 | Series B | 3 | $18.5M |
Growth Capital Fund Telegraph Hill Partners PTV Healthcare Capital Growth Capital Fund Telegraph Hill Partners PTV Healthcare Capital |
6/2006 | Series A | 2 | $49M |
Growth Capital Fund Telegraph Hill Partners Telegraph Hill Partners Growth Capital Fund Telegraph Hill Partners Telegraph Hill Partners |
3/2013 | Venture Round | $7.5M | 7/2011 | Equity | $5M | 10/2007 | Funding Round | 1 | - |
Merck Global Health Innovation Fund Merck Global Health Innovation Fund |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|